david swoboda talks mds highlights at ash 2023
Published 10 months ago • 343 plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
7:24
advancements in aml & mds: genetic sequencing & immune therapies | david swoboda, md | asco 2023
-
48:49
is mds cancer? navigating your mds diagnosis | dr. david swoboda
-
1:25
dr. venugopal highlights myelofibrosis research at ash 2023
-
9:47
jennifer woyach, md, highlights novel cll therapies presented at ash 2023
-
3:24
how are erythropoiesis-stimulating agents used in mds care today?
-
4:22
matthew davids, md, discusses zuma-8 at ash
-
3:36
azacitidine and venetoclax for high-risk #mds patients | jacqueline s. garcia, md | ash 2023
-
10:30
blood cancers explained: leukemia, myeloma, lymphoma, and more
-
17:10
blood cancers: haematological malignancies
-
7:26
leukemia: signs, symptoms, treatment | max hospital
-
3:01
how is mds classification, prognosis changing?
-
16:28
ash 2023 leukemia/mds/myelofibrosis highlights – transform-1, manifest-2, save, augment-101
-
12:19
the hemonc pulse live at ash: phillip scheinberg, md, on chip, mds classification updates
-
39:15
documentary - 50 years of ash and hematology
-
1:57
safety and efficacy of sx-682 in hma failure mds
-
9:30
what major themes define recent lower-risk mds prognostication, treatment?
-
0:15
3 year cancer survivor - stage 4 breast cancer at 22 #shorts
-
0:30
symptoms of leukemia
-
2:00
key updates in mds from ash on magrolimab, sabatolimab, venetoclax & tamibarotene
-
1:16:36
highlights from the 2019 ash annual meeting
-
1:21
hodgkin lymphoma highlights from ash 2023: nivo-avd versus bv-avd in patients with hl